Please wait while the formulary information is being retrieved.
CHLOROTHIAZIDE SODIUM (CHLOROTHIAZIDE SODIUM)
- Edema
- Hypertension
- Peripheral edema due to chronic heart failure
- Pulmonary edema due to chronic heart failure
- Diuril Iv Solution
- Diuril Intravenous Solution
- Chlorothiazide Sodium Intravenous Solution
- By Indication
Diuril 500 mg intravenous solution
- Inject 500 mg by intravenous route 2 times per day
Diuril 500 mg intravenous solution
- Inject 500 mg by intravenous route 2 times per day
500 mg intravenous solution
- Inject 500 mg by intravenous route 2 times per day
Edema
- Inject 500 mg by intravenous route once daily
- Inject 500 mg by intravenous route 2 times per day
- Inject 1 gram by intravenous route once daily
- Inject 1 gram by intravenous route 2 times per day
Hypertension
- Inject 500 mg by intravenous route once daily
- Inject 500 mg by intravenous route 2 times per day
- Inject 1 gram by intravenous route once daily
- Inject 1 gram by intravenous route 2 times per day
- Inject 250 mg by intravenous route 2 times per day
Peripheral edema due to chronic heart failure
- Inject 500 mg by intravenous route once daily
- Inject 500 mg by intravenous route 2 times per day
- Inject 1 gram by intravenous route once daily
- Inject 1 gram by intravenous route 2 times per day
Pulmonary edema due to chronic heart failure
- Inject 500 mg by intravenous route once daily
- Inject 500 mg by intravenous route 2 times per day
- Inject 1 gram by intravenous route once daily
- Inject 1 gram by intravenous route 2 times per day
- dofetilide
- Tikosyn
Contraindicated
- Curad Enema
- Disposable Enema
- Enema
- Enema Disposable
- Fleet Enema
- Fleet Enema Extra
- Fleet Pediatric
- lithium carbonate
- lithium citrate
- Lithobid
- methenamine mand-sod biphos
- Oral Saline Laxative
- Osmoprep
- Phosphate Laxative
- Preparation Cleansing
- Ready-to-use Enema
- Reclast
- sod phos mono-sod phos dibasic
- sodium phosphates
- Uroqid-acid No.2
- zoledronic acid
- zoledronic acid-mannitol-water
- Zometa
Severe
Moderate
- acarbose
- Amaryl
- Apidra
- Apidra Solostar
- cholestyramine (with sugar)
- Cholestyramine Light
- cholestyramine-aspartame
- Colestid
- Colestid Flavored
- colestipol
- Diabeta
- diazoxide
- Digox
- digoxin
- Duetact
- glimepiride
- glipizide
- glipizide-metformin
- Glucotrol
- Glucotrol Xl
- Glucovance
- glyburide
- glyburide micronized
- glyburide-metformin
- Glynase
- Glyset
- Humalog
- Humalog Kwikpen
- Humalog Mix 50-50
- Humalog Mix 50-50 Kwikpen
- Humalog Mix 75-25
- Humalog Mix 75-25 Kwikpen
- Humulin 70/30
- Humulin N
- Humulin N Kwikpen
- Humulin R
- Humulin R U-500 "Concentrated"
- insulin asp prt-insulin aspart
- insulin aspart
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin lispro
- insulin lispro protam-lispro
- insulin NPH and regular human
- insulin regular hum U-500 conc
- insulin regular human
- Lanoxin
- Lanoxin Pediatric
- Lantus
- Lantus Solostar
- Levemir
- Levemir Flexpen
- miglitol
- nateglinide
- Novolin 70/30
- Novolin N
- Novolin R
- Novolog
- Novolog Flexpen
- Novolog Mix 70-30
- Novolog Mix 70-30 Flexpen
- Novolog Penfill
- NPH insulin human recomb
- pioglitazone-glimepiride
- Precose
- Prevalite
- Proglycem
- Questran
- Questran Light
- Starlix
- tolazamide
- tolbutamide
- Anuria
Contraindicated
- Disease of liver
- Neonatal hyperbilirubinemia
- Oliguria
- Severe renal impairment
- Systemic lupus erythematosus
Severe
Moderate
- Acute pancreatitis
- Diabetes mellitus
- Gout
- Hypercalcemia
- Hypercholesterolemia
- Hypertriglyceridemia
- Hyperuricemia
- Hypokalemia
- Hypomagnesemia
- Hyponatremia
- Sympathectomy
CHLOROTHIAZIDE SODIUM (CHLOROTHIAZIDE SODIUM)
- Edema
- Hypertension
- Peripheral edema due to chronic heart failure
- Pulmonary edema due to chronic heart failure
- Hypochloremic alkalosis
- Hypokalemia
- Hyponatremia
- Hypotension
- None
More Frequent
Severe
Less Severe
- Hyperglycemia
- Hypomagnesemia
- Kidney disease with reduction in GFR
- Abdominal pain with cramps
- Abnormal sexual function
- Anorexia
- Diarrhea
- Dizziness
- Fatigue
- Nausea
- Orthostatic hypotension
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute pancreatitis
- Agranulocytosis
- Anaphylaxis
- Aplastic anemia
- Erythema multiforme
- Exfoliative dermatitis
- Gout
- Hemolytic anemia
- Hepatitis
- Hypercalcemia
- Hyperparathyroidism
- Hypersensitivity angiitis
- Hyperuricemia
- Interstitial nephritis
- Interstitial pneumonitis
- Jaundice
- Leukopenia
- Myopia
- Neutropenic disorder
- Obstructive hyperbilirubinemia
- Purpura
- Secondary angle-closure glaucoma
- Squamous cell carcinoma of skin
- Stevens-johnson syndrome
- Systemic lupus erythematosus
- Thrombocytopenic disorder
- Toxic epidermal necrolysis
- Vasculitis
Less Severe
- Basal cell carcinoma of skin
- Blurred vision
- Constipation
- Erectile dysfunction
- Fever
- Gastrointestinal irritation
- General weakness
- Headache disorder
- Hypercholesterolemia
- Hypertriglyceridemia
- Muscle spasm
- Nervousness
- Paresthesia
- Sialoadenitis
- Skin rash
- Urticaria
- Vertigo
- Xanthopsia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Chlorothiazide(Sodium)
May increase bilirubin. Caution in jaundiced infants.
- 1 Day – 29 Days
- May increase bilirubin. Caution in jaundiced infants.
Chlorothiazide
- Severity Level:
C
- Additional Notes: Not recommended in pre-eclampsia and other pregnancy-induced hypertension.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Chlorothiazide
Limited data suggest excretion is minimal, larger dose may affect milk
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest excretion is minimal, larger dose may affect milk |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Chlorothiazide (injectable)
Cardiovascular-Elderly are more sensitive to hypotensive effects. Metabolic-Elderly are more sensitive to drug induced electrolyte loss. Monitor serum potassium, magnesium, and sodium. Endocrine-May exacerbate SIADH.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | N | N | Y |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- None
| Edema | |
| R60 | Edema, not elsewhere classified |
| R60.0 | Localized edema |
| R60.1 | Generalized edema |
| R60.9 | Edema, unspecified |
| Hypertension | |
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| Peripheral edema due to chronic heart failure | |
| R60 | Edema, not elsewhere classified |
| R60.9 | Edema, unspecified |
| Pulmonary edema due to chronic heart failure | |
| J81.0 | Acute pulmonary edema |
| 0-9 | A-Z |
|---|---|
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| J81.0 | Acute pulmonary edema |
| R60 | Edema, not elsewhere classified |
| R60 | Edema, not elsewhere classified |
| R60.0 | Localized edema |
| R60.1 | Generalized edema |
| R60.9 | Edema, unspecified |
| R60.9 | Edema, unspecified |
Formulary Reference Tool